Major depressive disorder (MDD) is a common mental illness that is incapacitating for many people. It has long been understood that MDD is influenced by both environmental and genetic factors.
Patients with treatment-resistant depression have a 23 per cent higher risk of death than other depressed patients. They also have twice as much outpatient care and spend three times the number of days in inpatient care. These are findings of a new study published in JAMA Psychiatry by resea
Washington [US], August 21 (ANI): According to the researchers, deep brain stimulation (DBS) to the superolateral branch of the medial forebrain bundle (MFB), which is linked to reward and motivation. The study revealed metabolic brain changes over 12 months after DBS implantation, making it
Washington [US], August 20 (ANI): Deep brain stimulation (DBS) to the superolateral branch of the medial forebrain bundle (MFB), which is linked to reward and motivation, revealed metabolic brain changes over 12 months post-DBS implantation, making it a strong potential therapy for treatment
Washington D.C., Aug. 12 (ANI): A new University of Pittsburgh School of Medicine study says that identifying and treating metabolic deficiencies in patients with treatment-resistant depression can improve symptoms and in some cases even lead to remission.